Live from the NIH registry
Studies recruiting near Worcester right now
Top 25 of 270 recruiting studies, sorted by proximity — each links to its official registry page
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Massachusetts Memorial Health — Worcester, Massachusetts (0.6 mi)
· Sponsor: Lupus Research Alliance
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Vitalix — Worcester, Massachusetts (0.6 mi)
· Sponsor: Teikoku Pharma USA, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Kura Oncology, Inc.
Individualizing Treatment for Asthma in Primary Care (Full Study)
Asthma, Asthma Attack
Phase 4
Interventional 3,200 participants sought
Reliant Medical Group — Worcester, Massachusetts (0.6 mi)
· Sponsor: DARTNet Institute
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: SWOG Cancer Research Network
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Alabama at Birmingham
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Colitis, Ulcerative
Phase 2, Phase 3
Interventional 120 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Phase 3
Interventional 300 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Eli Lilly and Company
Energy Dense Fueling for Cold-Weather Operations
Cold Exposure
N/A
Interventional 8 participants sought
USARIEM — Natick, Massachusetts (23.5 mi)
· Sponsor: United States Army Research Institute of Environmental Medicine
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
University of Massachusetts Memorial Healthcare — Worcester, Massachusetts (0.6 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Intravenous Iron Effects on Performance at High Altitude
Hypoxia
Phase 4
Interventional 24 participants sought
USARIEM — Natick, Massachusetts (23.5 mi)
· Sponsor: United States Army Research Institute of Environmental Medicine
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Penumbra Inc.
Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women
Contraception, Iron Deficiencies
N/A
Observational 33 participants sought
US Army Research Institute of Environmental Medicine — Natick, Massachusetts (23.5 mi)
· Sponsor: United States Army Research Institute of Environmental Medicine
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Magenta Medical Ltd.
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Critical Limb Ischemia, Chronic Limb-Threatening Ischemia
N/A
Interventional 100 participants sought
UMass Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: LimFlow, Inc.
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 614 participants sought
University of Massachusetts Chan Medical School-Division of Hematology/Oncology ( Site 0144) — Worcester, Massachusetts (0.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
University of Massachusetts Memorial Health Care — Worcester, Massachusetts (0.6 mi)
· Sponsor: Nicole Hamblett
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
COPD (Chronic Obstructive Pulmonary Disease)
N/A
Interventional 50 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
Vitalix Clinical — Worcester, Massachusetts (0.6 mi)
· Sponsor: Syndeio Biosciences, Inc
Promoting Early Intervention Timing and Attention to Language
MONITOR, COACH
N/A
Interventional 140 participants sought
University of Massachusetts Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of California, Los Angeles
Skilled Nursing Facility at Home Trial
Skilled Nursing Facility, Rehabilitation
N/A
Interventional 650 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
New England Regional Headache Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
SAINT in Postpartum Depression (PPD)
Postpartum Depression (PPD)
N/A
Interventional 192 participants sought
UMass Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Magnus Medical